{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:07:01Z","timestamp":1790960821277,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10096-025-05215-4","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T17:29:32Z","timestamp":1752773372000},"page":"2475-2486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical features and risk factors for severe macrolide-resistant mycoplasma pneumoniae pneumonia induced by 23\u00a0S rRNA A2063G mutation: a retrospective observational study"],"prefix":"10.1007","volume":"44","author":[{"given":"Wenrui","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houxi","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"5215_CR1","doi-asserted-by":"publisher","unstructured":"Kim K, Jung S, Kim M, Park S, Yang H-J, Lee E Global trends in the proportion of Macrolide-Resistant\u2009<\u2009i\u2009>\u2009Mycoplasma p neumoniae\u2009infections. JAMA Netw Open, 5(7):e2220949. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.20949","DOI":"10.1001\/jamanetworkopen.2022.20949"},{"issue":"7","key":"5215_CR2","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1007\/s00431-024-05519-1","volume":"183","author":"G Ding","year":"2024","unstructured":"Ding G, Zhang X, Vinturache A, van Rossum AMC, Yin Y, Zhang Y (2024) Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia. Eur J Pediatr 183(7):3001\u20133011. https:\/\/doi.org\/10.1007\/s00431-024-05519-1","journal-title":"Eur J Pediatr"},{"key":"5215_CR3","doi-asserted-by":"publisher","unstructured":"Lanata MM, Wang H, Everhart K, Moore-Clingenpeel M, Ramilo O, Leber A Macrolide-Resistant\u2009<\u2009i\u2009>\u2009Mycoplasma pneumoniae\u2009infections in Childre n, ohio, USA. Emerg Infect Dis, 27(6):1588\u20131597https:\/\/doi.org\/10.3201\/eid2706.203206","DOI":"10.3201\/eid2706.203206"},{"key":"5215_CR4","doi-asserted-by":"publisher","unstructured":"Oishi T, Ouchi K Recent trends in the epidemiology, diagnosis, and treatment of Macroli de-Resistant Mycoplasma pneumoniae. JCM, 11(7):1782https:\/\/doi.org\/10.3390\/jcm11071782","DOI":"10.3390\/jcm11071782"},{"key":"5215_CR5","doi-asserted-by":"publisher","unstructured":"Lee JK, Lee T, Kim Y-J, Kim DR, Shin A, Kang HM, Kim YJ, Kim DH, Eun BW, Choe YJ et al Clinical manifestations, macrolide resistance, and treatment utilizati on trends of Mycoplasma pneumoniae pneumonia in children and Adolescen Ts in South Korea. Microorganisms, 12(9):1806https:\/\/doi.org\/10.3390\/microorganisms12091806","DOI":"10.3390\/microorganisms12091806"},{"issue":"7","key":"5215_CR6","doi-asserted-by":"publisher","first-page":"e2220949","DOI":"10.1001\/jamanetworkopen.2022.20949","volume":"5","author":"K Kim","year":"2022","unstructured":"Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E (2022) Global trends in the proportion of Macrolide-Resistant Mycoplasma pneumoniae infections: A systematic review and Meta-analysis. JAMA Netw Open 5(7):e2220949. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.20949","journal-title":"JAMA Netw Open"},{"key":"5215_CR7","doi-asserted-by":"publisher","unstructured":"Leng M, Yang J, Liu X (2024) Macrolide-resistant mycoplasma pneumoniae infection in children observed during a period of high incidence in Henan, China. Heliyon 10(13):e33697https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33697","DOI":"10.1016\/j.heliyon.2024.e33697"},{"key":"5215_CR8","doi-asserted-by":"publisher","unstructured":"Contes KM, Liu BM (2025) Epidemiology, clinical significance, and diagnosis of respiratory viruses and their Co-Infections in the Post-COVID era. Pathogens 14(3). https:\/\/doi.org\/10.3390\/pathogens14030262","DOI":"10.3390\/pathogens14030262"},{"key":"5215_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fmicb.2016.00329","volume":"7","author":"PM Meyer Sauteur","year":"2016","unstructured":"Meyer Sauteur PM, Unger WW, Nadal D, Berger C, Vink C, van Rossum AM (2016) Infection with and carriage of Mycoplasma pneumoniae in children. Front Microbiol 7:329. https:\/\/doi.org\/10.3389\/fmicb.2016.00329","journal-title":"Front Microbiol"},{"key":"5215_CR10","doi-asserted-by":"publisher","unstructured":"Jiang Y, Dou H, Xu B, Xu B, Zhou W, Wang H, Ge L, Hu Y, Han X, Qin X et al (2024) Macrolide resistance of Mycoplasma pneumoniae in several regions of China from 2013 to 2019. Epidemiol Infect 152e75. https:\/\/doi.org\/10.1017\/s0950268824000323","DOI":"10.1017\/s0950268824000323"},{"issue":"1","key":"5215_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12866-024-03180-0","volume":"24","author":"M Xu","year":"2024","unstructured":"Xu M, Li Y, Shi Y, Liu H, Tong X, Ma L, Gao J, Du Q, Du H, Liu D et al (2024) Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, wuhan, 2020\u20132022. BMC Microbiol 24(1):23. https:\/\/doi.org\/10.1186\/s12866-024-03180-0","journal-title":"BMC Microbiol"},{"key":"5215_CR12","doi-asserted-by":"publisher","unstructured":"Chen Y, Jia X, Gao Y, Ren X, Du B, Zhao H, Feng Y, Xue G, Cui J, Gan L et al (2024) Increased macrolide resistance rate of Mycoplasma pneumoniae correlated with epidemic in beijing, China in 2023. Front Microbiol 151449511. https:\/\/doi.org\/10.3389\/fmicb.2024.1449511","DOI":"10.3389\/fmicb.2024.1449511"},{"key":"5215_CR13","doi-asserted-by":"publisher","first-page":"1483152","DOI":"10.3389\/fmicb.2024.1483152","volume":"15","author":"L Xu","year":"2024","unstructured":"Xu L, Wang P, Wang Y, Liu B, Xu X, Yang Q, Gao C, Sun H, Xu Y, Xu Q et al (2024) Epidemiological, clinical, and genotypic characteristics of pediatric Mycoplasma pneumoniae infections: an 8-year survey in suzhou, China in the pre- and post-COVID-19 eras. Front Microbiol 15:1483152. https:\/\/doi.org\/10.3389\/fmicb.2024.1483152","journal-title":"Front Microbiol"},{"key":"5215_CR14","doi-asserted-by":"publisher","unstructured":"Dekyi XY, Wang X, Feng S, Wang Y, Liao L, Wang S, Deng Y, Zheng J, Zhao D (2024) Predominance of A2063G mutant strains in the Mycoplasma pneumoniae epidemic in children: A clinical and epidemiological study in 2023 in wuhan, China. Int J Infect Dis 145107074. https:\/\/doi.org\/10.1016\/j.ijid.2024.107074","DOI":"10.1016\/j.ijid.2024.107074"},{"issue":"9","key":"5215_CR15","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s10096-024-04902-y","volume":"43","author":"M Yan","year":"2024","unstructured":"Yan M, Tao R, Li S, Xiong J, Xiang J (2024) Clinical characteristics and logistic regression analysis of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Eur J Clin Microbiol Infect Dis 43(9):1825\u20131835. https:\/\/doi.org\/10.1007\/s10096-024-04902-y","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5215_CR16","doi-asserted-by":"publisher","DOI":"10.19871\/j.cnki.xfcrbzz.2024.01.015","author":"QS Zhao Shunying","year":"2024","unstructured":"Zhao Shunying QS, Chen Z, Hengmiao G, Hanmin L, Hailin Z, Jinrong L (2024) Guidelines for diagnosis and treatment of Mycoplasma Pneumonae pneumonia in children (2023 Edition). Electron J Emerg Infect Dis. https:\/\/doi.org\/10.19871\/j.cnki.xfcrbzz.2024.01.015","journal-title":"Electron J Emerg Infect Dis"},{"issue":"09","key":"5215_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.13558\/j.cnki.issn1672-3686.2019.09.002","volume":"17","author":"N Xin","year":"2019","unstructured":"Xin N (2019) Diagnosis and treatment guidelines for children\u2019s Community-Acquired pneumonia (2019 edition). Clin Educ Gen Pract 17(09):771\u2013777. https:\/\/doi.org\/10.13558\/j.cnki.issn1672-3686.2019.09.002","journal-title":"Clin Educ Gen Pract"},{"issue":"5","key":"5215_CR18","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jmii.2021.07.011","volume":"55","author":"JK Lee","year":"2022","unstructured":"Lee JK, Choi YY, Sohn YJ, Kim KM, Kim YK, Han MS, Park JY, Cho EY, Choi JH, Choi EH (2022) Persistent high macrolide resistance rate and increase of macrolide-resistant ST14 strains among Mycoplasma pneumoniae in South korea, 2019\u20132020. J Microbiol Immunol Infect 55(5):910\u2013916. https:\/\/doi.org\/10.1016\/j.jmii.2021.07.011","journal-title":"J Microbiol Immunol Infect"},{"issue":"8","key":"5215_CR19","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1128\/aac.00663-13","volume":"57","author":"Y Kawai","year":"2013","unstructured":"Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y, Saito A, Kondo E, Teranishi H, Wakabayashi T et al (2013) Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Antimicrob Agents Chemother 57(8):4046\u20134049. https:\/\/doi.org\/10.1128\/aac.00663-13","journal-title":"Antimicrob Agents Chemother"},{"key":"5215_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13756-019-0469-7","volume":"8","author":"F Zhao","year":"2019","unstructured":"Zhao F, Liu J, Shi W, Huang F, Liu L, Zhao S, Zhang J (2019) Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in beijing, china, from 2014 to 2016. Antimicrob Resist Infect Control 8:18. https:\/\/doi.org\/10.1186\/s13756-019-0469-7","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"5215_CR21","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/aac.02060-12","volume":"57","author":"F Zhao","year":"2013","unstructured":"Zhao F, Liu G, Wu J, Cao B, Tao X, He L, Meng F, Zhu L, Lv M, Yin Y et al (2013) Surveillance of macrolide-resistant Mycoplasma pneumoniae in beijing, china, from 2008 to 2012. Antimicrob Agents Chemother 57(3):1521\u20131523. https:\/\/doi.org\/10.1128\/aac.02060-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5215_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/crj.12379","volume":"11","author":"B Cao","year":"2017","unstructured":"Cao B, Qu JX, Yin YD, Eldere JV (2017) Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. Clin Respir J 11(4):419\u2013429. https:\/\/doi.org\/10.1111\/crj.12379","journal-title":"Clin Respir J"},{"issue":"3","key":"5215_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/cmr.00114-16","volume":"30","author":"KB Waites","year":"2017","unstructured":"Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP (2017) Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev 30(3):747\u2013809. https:\/\/doi.org\/10.1128\/cmr.00114-16","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"5215_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/idr13030073","volume":"13","author":"D Loconsole","year":"2021","unstructured":"Loconsole D, De Robertis AL, Sallustio A, Centrone F, Morcavallo C, Campanella S, Accogli M, Chironna M (2021) Update on the epidemiology of Macrolide-Resistant Mycoplasma pneumoniae in europe: A systematic review. Infect Dis Rep 13(3):811\u2013820. https:\/\/doi.org\/10.3390\/idr13030073","journal-title":"Infect Dis Rep"},{"issue":"1","key":"5215_CR25","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1080\/22221751.2022.2078228","volume":"11","author":"X Wang","year":"2022","unstructured":"Wang X, Li M, Luo M, Luo Q, Kang L, Xie H, Wang Y, Yu X, Li A, Dong M et al (2022) Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in beijing: a multicentre, population-based epidemiological study between 2015 and 2020. Emerg Microbes Infect 11(1):1508\u20131517. https:\/\/doi.org\/10.1080\/22221751.2022.2078228","journal-title":"Emerg Microbes Infect"},{"key":"5215_CR26","doi-asserted-by":"publisher","first-page":"1388132","DOI":"10.3389\/fped.2024.1388132","volume":"12","author":"H Du","year":"2024","unstructured":"Du H, Li J, Li X, Zhao J, Lu W, Zhang Q, Liu W, Luo X, Lu Q, Hu S et al (2024) Impact of the COVID-19 pandemic on epidemiological and clinical characteristics of Mycoplasma pneumoniae pneumonia in children: a multicenter study from hubei, China. Front Pediatr 12:1388132. https:\/\/doi.org\/10.3389\/fped.2024.1388132","journal-title":"Front Pediatr"},{"issue":"7","key":"5215_CR27","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3760\/cma.j.cn112150-20231123-00368","volume":"58","author":"BB Mao","year":"2024","unstructured":"Mao BB, Chen DN, Lu WW, Liu CY, Li ZL, Chen CS, Qiu HY, Liu WY (2024) [Epidemic characteristics of mycoplasma pneumoniae infection and drug-resistant gene mutations in hospitalized children aged 0\u201317 in Ningbo City from 2019 to 2023]. Zhonghua Yu Fang Yi Xue Za Zhi 58(7):1035\u20131040. https:\/\/doi.org\/10.3760\/cma.j.cn112150-20231123-00368","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"5215_CR28","doi-asserted-by":"publisher","first-page":"1427702","DOI":"10.3389\/fmicb.2024.1427702","volume":"15","author":"X Zhu","year":"2024","unstructured":"Zhu X, Liu P, Yu H, Wang L, Zhong H, Xu M, Lu L, Jia R, Su L, Cao L et al (2024) An outbreak of Mycoplasma pneumoniae in children after the COVID-19 pandemic, shanghai, china, 2023. Front Microbiol 15:1427702. https:\/\/doi.org\/10.3389\/fmicb.2024.1427702","journal-title":"Front Microbiol"},{"issue":"1","key":"5215_CR29","doi-asserted-by":"publisher","first-page":"e70136","DOI":"10.1002\/jmv.70136","volume":"97","author":"BM Liu","year":"2025","unstructured":"Liu BM, Yao Q, Cruz-Cosme R, Yarbrough C, Draper K, Suslovic W, Muhammad I, Contes KM, Hillyard DR, Teng S et al (2025) Genetic conservation and diversity of SARS-CoV-2 envelope gene across variants of concern. J Med Virol 97(1):e70136. https:\/\/doi.org\/10.1002\/jmv.70136","journal-title":"J Med Virol"},{"key":"5215_CR30","doi-asserted-by":"publisher","unstructured":"Cheng J, Liu Y, Zhang G, Tan L, Luo Z Azithromycin effectiveness in children with mutated Mycoplasma Pneumon Iae pneumonia. IDR, 17:2933\u20132942https:\/\/doi.org\/10.2147\/idr.s466994","DOI":"10.2147\/idr.s466994"},{"key":"5215_CR31","doi-asserted-by":"publisher","unstructured":"Zhang Y-x, Li Y, Wang Y, Ren Y-f, Yang Y, Qi J, Yang H, Liang X, Zhang R -f: prospective cohort study on the clinical significance of interferon-\u03b3, D-dimer, LDH, and CRP tests in children with severe mycoplasma Pneumo Nia. Medicine, 103(41):e39665. https:\/\/doi.org\/10.1097\/md.0000000000039665","DOI":"10.1097\/md.0000000000039665"},{"key":"5215_CR32","doi-asserted-by":"publisher","unstructured":"Huang W, Xu X, Zhao W, Cheng Q (2022) Refractory Mycoplasma pneumonia in children: A systematic review and Meta-analysis of laboratory features and predictors. J Immunol Res 2022(9227838). https:\/\/doi.org\/10.1155\/2022\/9227838","DOI":"10.1155\/2022\/9227838"},{"key":"5215_CR33","doi-asserted-by":"publisher","unstructured":"Wang C, Wen J, Yan Z, Zhou Y, Gong Z, Luo Y, Li Z, Zheng K, Zhang H, Ding N et al Suppressing neutrophil Itaconate production attenuates Mycoplasma Pneu moniae Pneumonia. PLoS Pathog, 20(11):e1012614https:\/\/doi.org\/10.1371\/journal.ppat.1012614","DOI":"10.1371\/journal.ppat.1012614"},{"key":"5215_CR34","doi-asserted-by":"publisher","unstructured":"Li Y-t, Zhang J, Wang M-z, Ma Y-M, Zhi K, Dai F-L, Li S-j Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity. Ital J Pediatr, 49(1). https:\/\/doi.org\/10.1186\/s13052-023-01545-1","DOI":"10.1186\/s13052-023-01545-1"},{"key":"5215_CR35","doi-asserted-by":"publisher","first-page":"687391","DOI":"10.3389\/fcimb.2021.687391","volume":"11","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Hua L, Zhao Q, Li M, Huang M, Zhou Y, Wang Y, Chen Z, Zhang Y (2021) The level of D-Dimer is positively correlated with the severity of Mycoplasma pneumoniae pneumonia in children. Front Cell Infect Microbiol 11:687391. https:\/\/doi.org\/10.3389\/fcimb.2021.687391","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"5215_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1089\/jir.2020.0210","volume":"40","author":"BM Liu","year":"2020","unstructured":"Liu BM, Hill HR (2020) Role of host immune and inflammatory responses in COVID-19 cases with underlying primary immunodeficiency: A review. J Interferon Cytokine Res 40(12):549\u2013554. https:\/\/doi.org\/10.1089\/jir.2020.0210","journal-title":"J Interferon Cytokine Res"},{"key":"5215_CR37","doi-asserted-by":"publisher","unstructured":"Lakshmanan K, Liu BM (2025) Impact of Point-of-Care testing on diagnosis, treatment, and surveillance of Vaccine-Preventable viral infections. Diagnostics (Basel) 15(2). https:\/\/doi.org\/10.3390\/diagnostics15020123","DOI":"10.3390\/diagnostics15020123"},{"issue":"9","key":"5215_CR38","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s12519-024-00831-0","volume":"20","author":"YS Wang","year":"2024","unstructured":"Wang YS, Zhou YL, Bai GN, Li SX, Xu D, Chen LN, Chen X, Dong XY, Fu HM, Fu Z et al (2024) Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. World J Pediatr 20(9):901\u2013914. https:\/\/doi.org\/10.1007\/s12519-024-00831-0","journal-title":"World J Pediatr"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05215-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05215-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05215-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:45:33Z","timestamp":1759239933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05215-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5215"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05215-4","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Ethics Review Committee of the Children\u2019s Hospital of Kunming Medical University. Due to the retrospective design of the study, the requirement for informed consent was waived by the ethics committee of Ethics Review Committee of the Children\u2019s Hospital of Kunming Medical University. In addition, all methods were carried out in accordance with relevant guidelines and regulations or Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}